Microglia as critical mediators linking perinatal immune stress to mental health trajectories

Ravikiran M Raju1,2,3, Caroline J Smith4

  • 1Division of Newborn Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Insights

Early life immune activation and stress impact microglia, the brain's immune cells. This review links these changes to neurodevelopmental disorders like autism and neuropsychiatric conditions such as depression and schizophrenia.

Area of Science:

  • Neuroscience
  • Immunology
  • Developmental Biology

Background:

  • Neurodevelopmental and neuropsychiatric disorders lack effective therapies, necessitating research into their origins.
  • Perinatal immune activation and stress are identified risk factors for these conditions.
  • Microglia, brain immune cells, are sensitive to early life events and implicated in these disorders.

Purpose of the Study:

  • To review literature on microglia-specific alterations due to early life immune activation and/or stress.
  • To examine microglial interactions with neural synapses and circuits in this context.
  • To connect these microglial changes to the pathogenesis of autism, depression, and schizophrenia.

Main Methods:

  • Literature review focusing on studies of microglia, early life insults, and neurodevelopmental/neuropsychiatric disorders.
  • Emphasis on research linking microglial function to synaptic and circuit alterations.
  • Synthesis of findings related to autism, depression, and schizophrenia.

Main Results:

  • Early life immune activation and stress induce specific changes in microglia.
  • These microglial alterations affect neural synapses and circuits.
  • Evidence suggests a role for these microglial changes in the development of autism, depression, and schizophrenia.

Conclusions:

  • Microglia are a critical link between early life insults and the development of neurodevelopmental and neuropsychiatric disorders.
  • Understanding microglia-specific mechanisms is key to bridging the gap between developmental insults and disease.
  • Further mechanistic research is needed to explore therapeutic targets.